Feasibility of the Combination of Venetoclax and Asparaginase-based Chemotherapy for Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier Inc.
Abstract
Description
Keywords
Bcl-2 inhibitor, Efficacy, Feasibility, Safety, Salvage therapy, Adult, Antineoplastic combined chemotherapy protocols, Asparaginase, Bridged bicyclo compounds, heterocyclic, Drug resistance, neoplasm, Feasibility studies, Female, Follow-up studies, Humans, Male, Middle aged, Neoplasm recurrence, local, Precursor cell lymphoblastic leukemia-lymphoma, Prognosis, Sulfonamides, Young adult, Amphotericin b, Blinatumomab, Busulfan, Caspofungin, Cd2 antigen, Cd3 antigen, Cd33 antigen, Cd34 antigen, Cd5 antigen, Cd7 antigen, Clofarabine, Cyclophosphamide, Cytarabine, Daunorubicin, Dexamethasone, Doxorubicin, Etoposide, Fludarabine, Idarubicin, Mercaptopurine, Methotrexate, Microsomal aminopeptidase, Myeloperoxidase, Prednisone, Rituximab, T6 antigen, Thiotepa, Venetoclax, Vincristine, Antineoplastic agent, Fused heterocyclic rings, Sulfonamide, Acute lymphoblastic leukemia, Article, Aspergillosis, Bone marrow biopsy, Cancer combination chemotherapy, Cancer patient, Case report, Cd3+ t lymphocyte, Clinical article, Colonoscopy, Debridement, Drug megadose, Feasibility study, Febrile neutropenia, Gastroscopy, Graft versus host reaction, Human, Induction chemotherapy, Intensive care unit, Maintenance chemotherapy, Minimal residual disease, Mucormycosis, Multiple cycle treatment, Myeloablative conditioning, Neutropenia, Neutrophil count, Pancytopenia, Positron emission tomography, Relapsed refractory acute lymphoblastic leukemia, Remission, Respiratory distress, Treatment interruption, Tumor cell destruction, Whole body radiation, Drug effect, Drug resistance, Follow up, Pathology, Tumor recurrence